Transforming Perception from Generic to Biopharma

Richard argues Teva has rebuilt its innovative muscle and is shifting to high-impact neuroscience and oncology programs.

Play episode from 40:25

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!